There are plenty of ASX growth shares for investors to choose from on the local market. But which ones could be top options ...
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...
When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in. The content of this article is provided for information ...
When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in. The content of this article is provided for information ...
Since going public in 2021, Rivian (NASDAQ: RIVN) has worked hard to become a household name. It's not quite there, but it is gaining recognition. The company recently received a J.D. Power award ...
Vertex Pharmaceuticals (NASDAQ: VRTX) is a fast-growing pharmaceutical company that investors have been bullish on for years. The business generates billions in revenue from cystic fibrosis drugs ...
Another earnings release appeared to leave Palantir (NYSE: PLTR) in a range-bound state. Shares had again surged above $25 per share, but investors sold the stock following the announcement of its ...
Welcome to the Trading Day blog for Tuesday, May 14. The ASX 200 closed 0.3 per cent lower at 7726.80 points. Global investors await US producer prices tonight and inflation data on Wednesday night.
But we believe there is a way that your global equities portfolio can enjoy the party, without having to dance too closely to ...